- Supported exchanges /
- F /
- 56F.F
EXACT THERAP. AS NK 0004 (56F F) stock market data APIs
EXACT Therapeutics AS, a clinical stage biopharmaceutical company, develops a technology platform for targeted therapeutic enhancement, Acoustic Cluster Therapy (ACT). The ACT is an approach to ultrasound-mediated, targeted drug enhancement with the potential to amplify the clinical utility of a range of therapeutic agents across various indications, including within oncology and brain diseases. The company's ACT platform is under Phase I clinical trial for treatment of liver metastases; and pre-clinical studies for pancreatic, glioblastoma, and immunotherapy diseases, as well as CNS diseases and gene therapy. EXACT Therapeutics AS has a collaboration with GE Healthcare for the development of a ready-to-use formulation of Sonazoid for ultrasound imaging and therapy; and with Agenus Inc. to develop proprietary immune checkpoint inhibitors in combination with EXACT's Acoustic Cluster Technology, in pancreatic cancer. The company was formerly known as Phoenix Solutions AS. EXACT Therapeutics AS was founded in 2012 and is based in Oslo, Norway.
EXACT THERAP. AS NK 0004 Financial Data Overview
| 0.476 | |
| 0.476 | |
| - | |
| 0.476 | |
| 0.476 | |
| 0.386-1.09 | |
| 15 634 K | |
| 32 081 K | |
| 0 | |
| 0.11 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
EXACT THERAP. AS NK 0004 Fundamental Data is available in our Financial Data APIs
- Net Revenue 0
- EBITDA -54 074 052
- Earnings Per Share -0.14
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get EXACT THERAP. AS NK 0004 Earnings via APIs
- Latest Release 2024-09-30
- EPS/Forecast NaN
Get EXACT THERAP. AS NK 0004 End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
